How much funding has Kelix Bio raised?

Kelix Bio has raised $200.0M in total funding, most recently a Private Equity round.

Who are Kelix Bio's investors?

Kelix Bio's investors include Development Partners International, Mubadala Investment Company, British International Investment, European Bank for Reconstruction and Development.

Where is Kelix Bio headquartered?

Kelix Bio is headquartered in Abu Dhabi, United Arab Emirates.

What industry is Kelix Bio in?

Kelix Bio operates in Biotech, Healthcare.

How many employees does Kelix Bio have?

Kelix Bio has 51-200 employees.

Kelix Bio

Acquired

Abu Dhabi, United Arab Emirates · Founded 2020 · $200.0M raised

Biotech

Healthcare

Headquarters: Abu Dhabi
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: kelixbio.com
Total Funding: $200.0M
Last Round: $200.0M Private EquityJan 2022
Rounds: 2

About

KELIX bio is an emerging markets-focused specialty generic biopharmaceutical company providing complex generics and high-complexity products to underserved populations across 40+ countries. Established in November 2020 and now a wholly owned subsidiary of Abu Dhabi sovereign wealth fund Mubadala Investment Company, the company operates a buy-and-build model, having expanded rapidly through acquisitions of manufacturing entities in India, Egypt, Malta, Morocco, and the UAE. KELIX bio competes through innovation and cost leadership in the specialty generics sector, with a focus on sterile liquid and lyophilized pharmaceuticals including antineoplastic products.

Summary

Kelix Bio is a Biotech company based in Abu Dhabi, United Arab Emirates, founded in 2020. It has raised $200.0M in total across 2 rounds, most recently a $200.0M Private Equity round in Jan 2022. Investors include Development Partners International, Mubadala Investment Company and British International Investment.